A citation-based method for searching scientific literature

Taku Kouro, Hidetomo Himuro, Tetsuro Sasada. J Transl Med 2022
Times Cited: 3







List of co-cited articles
2 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Glypican-3-Specific CAR T Cells Coexpressing IL15 and IL21 Have Superior Expansion and Antitumor Activity against Hepatocellular Carcinoma.
Sai Arun Batra, Purva Rathi, Linjie Guo, Amy N Courtney, Julien Fleurence, Julien Balzeau, Rahamthulla S Shaik, Thao P Nguyen, Meng-Fen Wu, Shaun Bulsara,[...]. Cancer Immunol Res 2020
80
66

The structural basis of T-cell receptor (TCR) activation: An enduring enigma.
Roy A Mariuzza, Pragati Agnihotri, John Orban. J Biol Chem 2020
40
66


CAR T-cell therapy: is it prime time in myeloma?
Surbhi Sidana, Nina Shah. Hematology Am Soc Hematol Educ Program 2019
15
33

CD28-ζ CAR T Cells Resist TGF-β Repression through IL-2 Signaling, Which Can Be Mimicked by an Engineered IL-7 Autocrine Loop.
Viktória Golumba-Nagy, Johannes Kuehle, Andreas A Hombach, Hinrich Abken. Mol Ther 2018
46
33

Reprogramming CD19-specific T cells with IL-21 signaling can improve adoptive immunotherapy of B-lineage malignancies.
Harjeet Singh, Matthew J Figliola, Margaret J Dawson, Helen Huls, Simon Olivares, Kirsten Switzer, Tiejuan Mi, Sourindra Maiti, Partow Kebriaei, Dean A Lee,[...]. Cancer Res 2011
139
33

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia.
Michael Kalos, Bruce L Levine, David L Porter, Sharyn Katz, Stephan A Grupp, Adam Bagg, Carl H June. Sci Transl Med 2011
33

Inducible Caspase-9 Selectively Modulates the Toxicities of CD19-Specific Chimeric Antigen Receptor-Modified T Cells.
Iulia Diaconu, Brandon Ballard, Ming Zhang, Yuhui Chen, John West, Gianpietro Dotti, Barbara Savoldo. Mol Ther 2017
140
33


Multiple myeloma.
Niels W C J van de Donk, Charlotte Pawlyn, Kwee L Yong. Lancet 2021
147
33

Multiple myeloma.
Antonio Palumbo, Kenneth Anderson. N Engl J Med 2011
33


Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning.
Hollie J Pegram, James C Lee, Erik G Hayman, Gavin H Imperato, Thomas F Tedder, Michel Sadelain, Renier J Brentjens. Blood 2012
446
33

Association of Minimal Residual Disease With Superior Survival Outcomes in Patients With Multiple Myeloma: A Meta-analysis.
Nikhil C Munshi, Herve Avet-Loiseau, Andy C Rawstron, Roger G Owen, J Anthony Child, Anjan Thakurta, Paul Sherrington, Mehmet Kemal Samur, Anna Georgieva, Kenneth C Anderson,[...]. JAMA Oncol 2017
303
33

Unbiased cell surface proteomics identifies SEMA4A as an effective immunotherapy target for myeloma.
Georgina S F Anderson, Jose Ballester-Beltran, George Giotopoulos, Jose A Guerrero, Sylvanie Surget, James C Williamson, Tsz So, David Bloxham, Anna Aubareda, Ryan Asby,[...]. Blood 2022
4
33

Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation Antigen.
Marijke Timmers, Gils Roex, Yuedi Wang, Diana Campillo-Davo, Viggo F I Van Tendeloo, Yiwei Chu, Zwi N Berneman, Feifei Luo, Heleen H Van Acker, Sébastien Anguille. Front Immunol 2019
55
33


Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma.
Gils Roex, Marijke Timmers, Kristien Wouters, Diana Campillo-Davo, Donovan Flumens, Wilfried Schroyens, Yiwei Chu, Zwi N Berneman, Eva Lion, Feifei Luo,[...]. J Hematol Oncol 2020
45
33

CARAMBA: a first-in-human clinical trial with SLAMF7 CAR-T cells prepared by virus-free Sleeping Beauty gene transfer to treat multiple myeloma.
Sabrina Prommersberger, Michael Reiser, Julia Beckmann, Sophia Danhof, Maximilian Amberger, Patricia Quade-Lyssy, Hermann Einsele, Michael Hudecek, Halvard Bonig, Zoltán Ivics. Gene Ther 2021
36
33

Chimeric antigen receptor therapy for cancer.
David M Barrett, Nathan Singh, David L Porter, Stephan A Grupp, Carl H June. Annu Rev Med 2014
237
33


Chimeric Antigen Receptor T-Cell Therapy in Multiple Myeloma-Challenges and Potential Solutions.
Samer Al Hadidi, Maurizio Zangari, Frits van Rhee. JAMA Oncol 2022
3
33

CD19 Isoforms Enabling Resistance to CART-19 Immunotherapy Are Expressed in B-ALL Patients at Initial Diagnosis.
Jeannette Fischer, Claudia Paret, Khalifa El Malki, Francesca Alt, Arthur Wingerter, Marie A Neu, Bettina Kron, Alexandra Russo, Nadine Lehmann, Lea Roth,[...]. J Immunother 2017
120
33


Homozygous BCMA gene deletion in response to anti-BCMA CAR T cells in a patient with multiple myeloma.
Matteo C Da Vià, Oliver Dietrich, Marietta Truger, Panagiota Arampatzi, Johannes Duell, Anke Heidemeier, Xiang Zhou, Sophia Danhof, Sabrina Kraus, Manik Chatterjee,[...]. Nat Med 2021
56
33


Hypoxia-inducible factors, stem cells, and cancer.
Brian Keith, M Celeste Simon. Cell 2007
841
33

An early history of T cell-mediated cytotoxicity.
Pierre Golstein, Gillian M Griffiths. Nat Rev Immunol 2018
106
33

Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study.
Jesus G Berdeja, Deepu Madduri, Saad Z Usmani, Andrzej Jakubowiak, Mounzer Agha, Adam D Cohen, A Keith Stewart, Parameswaran Hari, Myo Htut, Alexander Lesokhin,[...]. Lancet 2021
246
33

Intravenous safety and pharmacokinetics of a novel dimerizer drug, AP1903, in healthy volunteers.
J D Iuliucci, S D Oliver, S Morley, C Ward, J Ward, D Dalgarno, T Clackson, H J Berger. J Clin Pharmacol 2001
86
33

Antibody-dependent cellular cytotoxicity (ADCC) is mediated by genetically modified antigen-specific human T lymphocytes.
Béatrice Clémenceau, Nicolas Congy-Jolivet, Géraldine Gallot, Régine Vivien, Joëlle Gaschet, Gilles Thibault, Henri Vié. Blood 2006
60
33

Development of CAR T Cells Expressing a Suicide Gene Plus a Chimeric Antigen Receptor Targeting Signaling Lymphocytic-Activation Molecule F7.
Christina Amatya, Melissa A Pegues, Norris Lam, Danielle Vanasse, Claudia Geldres, Stephanie Choi, Stephen M Hewitt, Steven A Feldman, James N Kochenderfer. Mol Ther 2021
30
33



Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety.
V Hoyos, B Savoldo, C Quintarelli, A Mahendravada, M Zhang, J Vera, H E Heslop, C M Rooney, M K Brenner, G Dotti. Leukemia 2010
369
33

The generation of antibody-secreting plasma cells.
Stephen L Nutt, Philip D Hodgkin, David M Tarlinton, Lynn M Corcoran. Nat Rev Immunol 2015
714
33


Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma.
Meenakshi Hegde, Amanda Corder, Kevin K H Chow, Malini Mukherjee, Aidin Ashoori, Yvonne Kew, Yi Jonathan Zhang, David S Baskin, Fatima A Merchant, Vita S Brawley,[...]. Mol Ther 2013
248
33


Risk Factors Associated with Durable Progression-Free Survival in Patients with Relapsed or Refractory Multiple Myeloma Treated with Anti-BCMA CAR T-cell Therapy.
Mingming Zhang, Linghui Zhou, Houli Zhao, Yanlei Zhang, Guoqing Wei, Ruimin Hong, Wenjun Wu, Huijun Xu, Linqin Wang, Fang Ni,[...]. Clin Cancer Res 2021
13
33

B cell maturation antigen-specific chimeric antigen receptor T cells for relapsed or refractory multiple myeloma: A meta-analysis.
Nico Gagelmann, Francis Ayuk, Djordje Atanackovic, Nicolaus Kröger. Eur J Haematol 2020
28
33

Chimeric antigen receptor-modified T cells for acute lymphoid leukemia.
Stephan A Grupp, Michael Kalos, David Barrett, Richard Aplenc, David L Porter, Susan R Rheingold, David T Teachey, Anne Chew, Bernd Hauck, J Fraser Wright,[...]. N Engl J Med 2013
33

CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity.
Elad Jacoby, Sang M Nguyen, Thomas J Fountaine, Kathryn Welp, Berkley Gryder, Haiying Qin, Yinmeng Yang, Christopher D Chien, Alix E Seif, Haiyan Lei,[...]. Nat Commun 2016
252
33


CD19-CAR-T Cells Bearing a KIR/PD-1-Based Inhibitory CAR Eradicate CD19+HLA-C1- Malignant B Cells While Sparing CD19+HLA-C1+ Healthy B Cells.
Lei Tao, Muhammad Asad Farooq, Yaoxin Gao, Li Zhang, Congyi Niu, Iqra Ajmal, Ying Zhou, Cong He, Guixia Zhao, Jie Yao,[...]. Cancers (Basel) 2020
14
33


A Rapamycin-Activated Caspase 9-Based Suicide Gene.
Maria Stavrou, Brian Philip, Charlotte Traynor-White, Christopher G Davis, Shimobi Onuoha, Shaun Cordoba, Simon Thomas, Martin Pule. Mol Ther 2018
37
33

Deciphering mechanisms of immune escape to inform immunotherapeutic strategies in multiple myeloma.
Muthulekha Swamydas, Elena V Murphy, James J Ignatz-Hoover, Ehsan Malek, James J Driscoll. J Hematol Oncol 2022
6
33

Targeting Proteasomes in Cancer and Infectious Disease: A Parallel Strategy to Treat Malignancies and Microbes.
James J Ignatz-Hoover, Elena V Murphy, James J Driscoll. Front Cell Infect Microbiol 2022
2
50

Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities.
Bénedith Oben, Guy Froyen, Kylee H Maclachlan, Daniel Leongamornlert, Federico Abascal, Binbin Zheng-Lin, Venkata Yellapantula, Andriy Derkach, Ellen Geerdens, Benjamin T Diamond,[...]. Nat Commun 2021
39
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.